Clinical Trial Update: Exploratory Study of the Effects of Peptide PMS-001 on Long-Delay Recall in Patients With Moderate to Severe Dementia [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 exploratory study evaluating the peptide PMS-001 on long-delay recall in patients with moderate to severe dementia; the trial status is NOT_YE…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dementia

Drugs mentioned

• PMS-001

Snippet

Sponsor: Ruijin Hospital | Conditions: Dementia | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING